Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer
- 31 March 2007
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5) , 763-767
- https://doi.org/10.1016/j.jsbmb.2006.12.074
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (K01CA103861)
This publication has 13 references indexed in Scilit:
- Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1α-Hydroxylase in Normal and Malignant Human ColonCancer Epidemiology, Biomarkers & Prevention, 2005
- Vitamin D and prevention of colorectal cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Vitamin D and Colon CarcinogenesisJournal of Nutrition, 2004
- 25-Hydroxyvitamin D3-1α-hydroxylase Expression in Normal and Malignant Human ColonJournal of Histochemistry & Cytochemistry, 2004
- Pancreatic cancer cells express 25-hydroxyvitamin D-1 -hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3Carcinogenesis: Integrative Cancer Research, 2004
- Vitamin D and Vitamin D Analogs as Cancer Chemopreventive AgentsNutrition Reviews, 2003
- Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signalingThe Journal of cell biology, 2001
- 25-Hydroxy-Vitamin D Metabolism in Human Colon Cancer Cells during Tumor ProgressionBiochemical and Biophysical Research Communications, 2001
- 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissueThe Lancet, 2001
- Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humansAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1999